← Open Payments lookup

AJMAL KHAN: Open Payments

NPI 1538251426 · CULLMAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,025 in 55 payments from 9 companies in 2025. Trend: 2023 $1,465 · 2024 $1,166 · 2025 $1,025

Food & beverage: $1,025
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.25$434
Neurocrine BioSciences, Inc.8$161
Teva Pharmaceuticals USA, Inc.8$156
Alkermes, Inc.3$61
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$61
Lundbeck LLC3$60
ABBVIE INC.3$56
Janssen Pharmaceuticals, Inc1$18
Otsuka America Pharmaceutical, Inc.1$16

Products named: COBENFY, INGREZZA, UZEDY, ABILIFY MAINTENA, AUSTEDO XR, ARISTADA, CAPLYTA, VRAYLAR.

Industry payments across AL — which companies pay providers there.